Business Standard

Unichem Laboratories receives USFDA approval for Amitriptyline HCl Tablets

Image

Capital Market
Unichem Laboratories is pleased to announce that it has received ANDA approval for its Amitriptyline HCl Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg from the United States Food and Drug Administration (USFDA) to market a generic version of ELAVIL (Amitriptyline Hydrochloride) 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg of AstraZeneca Pharmaceuticals LP.

Amitriptyline HCl Tablets are indicated for the relief of symptoms of depression. The product will be commercialized from Unichem's Goa Plant.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 20 2021 | 3:53 PM IST

Explore News